Issues related to domestic pharmaceutical manufacturing.
2026 · 1st Quarter (Jan 1 - Mar 31)
GLENMARK PHARMACEUTICALS
Filed by BOSE PUBLIC AFFAIRS GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Apr 17, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- BOSE PUBLIC AFFAIRS GROUP
- Client
- GLENMARK PHARMACEUTICALS
- Filing UUID
- 090fb4df-3452-4954-ba7a-20f5ba095610
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.